Gender differences in cardiometabolic risks among young adults
https://doi.org/10.17802/2306-1278-2021-10-2S-94-98
Abstract
Aim. To carry out a comparative assessment of cardiometabolic risk factors in men and women aged 18–44 years.
Methods. The cross-sectional study included 251 patients divided into 2 groups. Group 1 consisted of 124 men; group 2 had 127 women in it. All participants of the study underwent anamnesis collection, blood pressure measurement, and assessment of anthropometric parameters, physical examination, biochemical and immunological tests.
Results. The most significant gender differences were noted in the levels of leptin and adiponectin, fibrinogen and plasminogen activator inhibitor type 1, angiotensin II and interleukin-10 in the blood serum with no differences in cardiometabolic risk factors, including glucose and lipid metabolism.
Conclusion. The revealed features of changes in adipokines and cytokines, indicators of hemostasis and vasoconstrictors in men and women expand the current knowledge about the role of some pathophysiological mechanisms in the development of cardiovascular pathology at a young age in the context of cardiometabolic risk concept.
About the Authors
V. S. Chulkov
South Ural State Medical University
Russian Federation
Russian Federation
PhD, Associate Professor/ Professor at the Department of Faculty Therapy,
64, Vorovskogo St., Chelyabinsk, 454092
E. A. Lenets
South Ural State Medical University
Russian Federation
Russian Federation
Resident at the Department of Faculty Therapy,
64, Vorovskogo St., Chelyabinsk, 454092
E. S. Gavrilova
South Ural State Medical University
Russian Federation
Russian Federation
PhD, Associate Professor at the Department of Polyclinic Therapy and Clinical Pharmacology,
64, Vorovskogo St., Chelyabinsk, 454092
E. E. Minina
South Ural State Medical University
Russian Federation
Russian Federation
senior laboratory assistant at the Department of Faculty Pediatrics named after N. S. Tyurina,
64, Vorovskogo St., Chelyabinsk, 454092
V. A. Pozdeeva
South Ural State Medical University
Russian Federation
Russian Federation
6th-year student at the Medical Department,
64, Vorovskogo St., Chelyabinsk, 454092
N. D. Ukolov
South Ural State Medical University
Russian Federation
Russian Federation
6th-year student at the Medical Department,
64, Vorovskogo St., Chelyabinsk, 454092
References
1. Després J.P., Cartier A., Côté M., Arsenault B.J. The concept of cardiometabolic risk: bridging the fields of diabetology and cardiology. Ann Med. 2008;40:514‐523. doi: 10.1080/07853890802004959.
2. Samorodskaya I.V., Bazdyrev E.D., Barbarash O.L. Cardiovascular risk factor paradox/ A focus on smoking. Complex Issues of Cardiovascular Diseases. 2019;8(1):90-99. (In Russian) doi: 10.17802/2306-1278-2019-8-1-90-99.
3. Puustinen P.J., Koponen H., Kautiainen H., MaNtyselka P., Vanhala M. Gender-specific association of psychological distress with cardiovascular risk scores. Scand J Prim Health Care 2010; 28(1): 36-40. doi: 10.3109/02813431003648131.
4. EUGenMed Cardiovascular Clinical Study Group, Regitz-Zagrosek V., Oertelt-Prigione S., Prescott E., Franconi F., Gerdts E., Foryst-Ludwig A., Maas A.H., Kautzky-Willer A., Knappe-Wegner D., Kintscher U., Ladwig K.H., SchenckGustafsson K., Stangl V. Gender in cardiovascular diseases: impact on clinical manifestations, management, and outcomes. Eur Heart J. 2016; 37(1):24–34. doi:10.1093/eurheartj/ehv598.
5. Shapovalova E.B., Maksimov S.A., Artamonova G.V. Gender differences of cardiovascular risk. Russian Journal of Cardiology. 2019; (4):99-104. (In Russian) doi:10.15829/1560-4071-2019-4-99-104.
6. Chulkov Vl.S., Vereina N.K., Chulkov V.S., Tarasova O.A., Sinitsyn S.P. Hemostais, adipokines, rennin-angiotensin system gene polymorphisms and target organ damage in young patients with hypertension and abdominal obesity. Therapy. 2019; 1 (26):82–88. doi: 10.18565/therapy.2019.1.82-88.
7. Chulkov V.S., Lenets E.A., Chulkov V.S., Gavrilova E.S., Minina E.E., Zhdanova O.V. Gender characteristics of the pathogenesis, prevention and treatment of metabolic syndrome. Arterial Hypertension. 2020; 26(4):371-382. (In Russ.) doi:10.18705/1607-419X-2020-26-4-371-382.
8. Sumerkina V.A., Chulkov V.S., Ozhigina E.V., Toropova L.R. Assessment of adipokine level in patients with metabolic syndrome and isolated abdominal obesity. Klin. Lab. Diagn. 2015; 9:62. (In Russian)
9. Sumerkina V.A., Chulkov V.S., Chulkov V.S., Golovneva E.S., Telesheva L.F., Mezentseva E.A., Nikushkina K.V. Evaluation of the hemostatic state, carbohydrate and lipid metabolism in young women with abdominal obesity and hypertension. Obesity and metabolism. 2015; 12(4):29-33. (In Russian) doi: 10.14341/omet2015429-33.
10. Dagdeviren S., Jung D.Y., Lee E., Friedline R.H., Noh H.L., Kim J.H., Patel P.R., Tsitsilianos N., Tsitsilianos A.V., Tran D.A., Tsougranis G.H., Kearns C.C., Uong C.P., Kwon J.Y., Muller W., Lee K.W., Kim J.K. Altered Interleukin-10 Signaling in Skeletal Muscle Regulates Obesity-Mediated Inflammation and Insulin Resistance. Mol Cell Biol. 2016; 36:2956–2966. doi: 10.1128/MCB.00181-16.
Review
For citations:
Chulkov V.S., Lenets E.A., Gavrilova E.S., Minina E.E., Pozdeeva V.A., Ukolov N.D. Gender differences in cardiometabolic risks among young adults. Complex Issues of Cardiovascular Diseases. 2021;10(2):94-98. (In Russ.) https://doi.org/10.17802/2306-1278-2021-10-2S-94-98
Views:
386
